Reply to the Letter by Derendorf: Clinical Trials and Dipyridamole Formulation Selection

Publisher： Karger

E-ISSN： 1421-9786|23|1|73-74

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.23, Iss.1, 2006-11, pp. : 73-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Trials and Dipyridamole Formulation Selection

By  

Cerebrovascular Diseases, Vol. 23, Iss. 1, 2006-11 ,pp. : 72-73

Karger

Access to resources Recommend Favorite

Reply to the Letter by van Breda et al.: Reduction of Body Temperature with Paracetamol in Patients with Acute Stroke: Randomized Clinical Trials Are Needed

By  

Cerebrovascular Diseases, Vol. 18, Iss. 4, 2004-12 ,pp. : 351-

Karger

Access to resources Recommend Favorite

Improving Patient Selection for Clinical Acute Stroke Trials

By  

Cerebrovascular Diseases, Vol. 21, Iss. 5-6, 2006-05 ,pp. : 386-392

Karger

Access to resources Recommend Favorite

Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection

By  

Liver Cancer, Vol. 5, Iss. 3, 2016-05 ,pp. : 221-232

Karger

Access to resources Recommend Favorite

Reply to letter to the editor

By Page R.E.   Peng C.Y.-S.  

Experimental Gerontology, Vol. 36, Iss. 10, 2001-11 ,pp. : 1775-1775

Elsevier

Access to resources Recommend Favorite